Psychometric analysis of the Korean version of the high-dose chemotherapy specific quality of life questionnaire module from the European Organization for Research and Treatment of Cancer (EORTC QLQ-HDC29)
参考文献:1.Gratwohl, M., Aljurf, M., Bouzas, L. F., Horowitz, M., Kodera, Y., Lipton, J., et al. (2013). Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: A Global Observational Study. Haematologica, 98(8), 1282–1290.CrossRef PubMed PubMedCentral 2.Gooley, T. A., Chien, J. W., Pergam, S. A., Hingorani, S., Sorror, M. L., Boeckh, M., et al. (2010). Reduced mortality after allogeneic hematopoietic-cell transplantation. New England Journal of Medicine, 363(22), 2091–2101.CrossRef PubMed PubMedCentral 3.Neitzert, C. S., Ritvo, P., Dancey, J., Weiser, K., Murray, C., & Avery, J. (1998). The psychosocial impact of bone marrow transplantation: A review of the literature. Bone Marrow Transplantation, 22(5), 409–422.CrossRef PubMed 4.McQuellon, R. P., Russell, G. B., Cella, D. F., Craven, B. L., Brady, M., Bonomi, A., & Hurd, D. D. (1997). Quality of life measurement in bone marrow transplantation: Development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplantation, 19(4), 357–368.CrossRef PubMed 5.Velikova, G., Weis, J., Hjermstad, M. J., Kopp, M., Morris, P., Watson, M., et al. (2007). The EORTC QLQ-HDC29: A supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. European Journal of Cancer, 43(1), 87–94.CrossRef PubMed 6.Dewolf, L., Koller, M., Velikova, G., Johnson, C., Scott, N., & Bottomley, A. (2009). EORTC quality of life group translation procedure (3rd ed.). Brussels: European Organisation for Research and Treatment of Cancer. 7.Tabachnik, B. J., & Fidel, L. S. (1993). Using multivariate statistics. London: Harper & Row. 8.Zubord, C., Scheiderman, M., & Frei, E. (1960). Appraisal of methods for the study of chemotherapy in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. Journal of Chronic Diseases, 11, 7–33.CrossRef 9.Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.CrossRef PubMed 10.Yun, Y. H., Park, Y. S., Lee, E. S., Bang, S. M., Heo, D. S., Park, S. Y., et al. (2004). Validation of the Korean version of the EORTC QLQ-C30. Quality of Life Research, 13(4), 863–868.CrossRef PubMed 11.Yoo, H., Lee, K., Lee, J., Eremenco, S., Choi, S., Kim, H., & Lee, J. (2006). Korean translation and validity of FACT-BMT version 4 and the quality of life in allogeneic bone marrow transplantation patients. Quality of Life Research, 15(3), 559–564.CrossRef PubMed 12.Ware, J. E., Harris, W. J., Gandek, B., Rogers, B. W., & Reese, P. R. (1997). MAP-R for Windows: Multitrait/multi-item analysis program—Revised user’s guide. Boston: Health Assessment Lab. 13.Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297.CrossRef 14.George, D., & Mallery, P. (2003). SPSS for Windows step by step: A simple guide and reference. 11.0 update (4th ed.). Boston: Allyn & Bacon. 15.Kline, P. (2000). The handbook of psychological testing (2nd ed.). London: Routledge. 16.Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Lawrence Erlbaum Associates. 17.Lee, Y., Lim, M. C., Son, Y., Joo, J., Park, K., Kim, J. S., et al. (2014). Development and evaluation of Korean version of Quality of Sexual Function (QSF-K) in healthy Korean women. Journal of Korean Medical Science, 29(6), 758–763.CrossRef PubMed PubMedCentral 18.Pallua, S., Giesinger, J., Oberguggenberger, A., Kemmler, G., Nachbaur, D., Clausen, J., et al. (2010). Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplantation, 45(10), 1534–1539.CrossRef PubMed 19.Braamse, A. M., Gerrits, M. M., van Meijel, B., Visser, O., van Oppen, P., Boenink, A. D., et al. (2012). Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies. Bone Marrow Transplantation, 47(6), 757–769.CrossRef PubMed 20.Baker, K. S., & Fraser, C. J. (2008). Quality of life and recovery after graft-versus-host disease. Best Practice & Research Clinical Haematology, 21(2), 333–341.CrossRef 21.Kiss, T. L., Abdolell, M., Jamal, N., Minden, M. D., Lipton, J. H., & Messner, H. A. (2002). Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 20(9), 2334–2343.CrossRef PubMed 22.Cella, D. (1997). Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system. Evanston, IL: Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University. 23.Syrjala, K. L., Langer, S. L., Abrams, J. R., Storer, B., Sanders, J. E., Flowers, M. E., & Martin, P. J. (2004). Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. Journal of the American Medical Association, 291(19), 2335–2343.CrossRef PubMed 24.Bevans, M. F., Marden, S., Leidy, N. K., Soeken, K., Cusack, G., Rivera, P., et al. (2006). Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 38(2), 101–109.CrossRef PubMed 25.Wong, F. L., Francisco, L., Togawa, K., Bosworth, A., Gonzales, M., Hanby, C., et al. (2010). Long-term recovery after hematopoietic cell transplantation: Predictors of quality-of-life concerns. Blood, 115(12), 2508–2519.CrossRef PubMed PubMedCentral
作者单位:Kyung Im Kim (1) Jae Hyun Kim (2) Eun Hee Ji (3) Jun Ho Jang (4) Jin Seok Kim (5) Ji-Hyun Kwon (6) Inho Kim (7) (8) (9) Seonyang Park (7) (8) (9) Galina Velikova (10) Sung-Soo Yoon (7) (8) (9) Jung Mi Oh (11) (2)
1. College of Pharmacy, Korea University, Sejong, Republic of Korea 2. College of Pharmacy, Seoul National University, Seoul, Republic of Korea 3. College of Pharmacy, Gachon University, Incheon, Republic of Korea 4. Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea 5. Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea 6. Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea 7. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea 8. Cancer Research Institute, Seoul National University, Seoul, Republic of Korea 9. Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea 10. Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds, UK 11. Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea
刊物类别:Medicine
刊物主题:Medicine & Public Health Quality of Life Research Sociology Public Health
出版者:Springer Netherlands
ISSN:1573-2649
文摘
Purpose We evaluated the psychometric properties of the Korean version of the European Organization for Research and Treatment of Cancer high-dose chemotherapy specific quality of life questionnaire module (EORTC QLQ-HDC29) when implemented with Korean patients by conducting a multicenter, longitudinal study in three Korean hospitals.